Vancomycin Hydrochloride for Injection — Class I drug recall D-0123-2018
Terminated recall by Pfizer Inc., reported 2017-12-27, distributed nationwide. Presence of Particulate Matter: glass particulate found in vial
| Recall number | D-0123-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2017-08-30 |
| Classified | 2017-12-20 |
| Reported by FDA | 2017-12-27 |
| Terminated | 2018-11-08 |
| Distributed | Nationwide (US) |
| Quantity | 102,500 vials |
| Reason classes | foreign material, specification failure |
| NDC | 00409-3515, 00409-3515-01, 00409-3515-11, 00409-4332, 00409-4332-01, 00409-4332-11, 00409-6531, 00409-6531-02, 00409-6531-12, 00409-6533, 00409-6533-01, 00409-6533-11, 00409-6533-21 |
| Lot numbers | 03/18, 632153A |
Product
Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02
Reason for recall
Presence of Particulate Matter: glass particulate found in vial
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0123-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.